Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 8:53 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 313–336 of 13,915 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Early Alzheimer's Disease
Interventions: Semagludtide, Placebo (semaglutide); Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 55 Years to 85 Years
Enrollment: 1,840 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 96
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Sun City, Arizona + 76 more

Conditions: Second Trimester Abortion
Interventions: Laminaria, Dilapan-S; Device
Lead sponsor: Planned Parenthood of Greater New York; Other
Eligibility: 18 Years and older · Female only
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Schizophrenia, Schizoaffective Disorder, Substance Use Disorders
Interventions: Brexpiprazole, Treatment as Usual; Drug · Other
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 4
States / cities: Augusta, Georgia • Boston, Massachusetts • Worcester, Massachusetts + 1 more

Conditions: Carcinoma, Hepatocellular
Interventions: Regorafenib in combination with pembrolizumab, Loco-regional therapy; Drug · Procedure
Lead sponsor: Translational Research in Oncology; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Subclinical Hypercortisolism, Cushing Syndrome, Adrenal Neoplasm
Interventions: Adrenalectomy, Observation; Procedure · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Respiratory Distress Syndrome, Newborn
Interventions: Betamethasone; Drug
Lead sponsor: Emory University; Other
Eligibility: Female only
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Cardiovascular Disease, Metabolic Syndrome
Interventions: Canola Oil, High oleic acid canola oil, Western diet oil combination; Other
Lead sponsor: Penn State University; Other
Eligibility: 20 Years to 65 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Neurofibromatosis 1, Social Skills
Interventions: PEERS; Behavioral
Lead sponsor: University of Wisconsin, Milwaukee; Other
Eligibility: 12 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Type 1 Diabetes
Interventions: Parental Support, Diabetes Education; Behavioral
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 1 Year to 6 Years
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Richmond, Virginia

Conditions: Myositis, Dermatomyositis, Polymyositis
Interventions: Healthy Control, Myositis in Remission; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Obesity
Interventions: Group 1 (First trimester ultrasound), Group 2 (Second trimester anatomy ultrasound); Diagnostic Test
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Alkaptonuria
Interventions: Nitisinone (NTBC); Drug
Lead sponsor: National Human Genome Research Institute (NHGRI); NIH
Eligibility: 30 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Pancreatic Carcinoma
Interventions: Best Practice, Quadratus Lumborum Block, Quality-of-Life Assessment, Questionnaire Administration; Other · Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Hypertension
Interventions: BP Activate Letter, Control Letter; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 484 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pareses, Lower Extremity
Interventions: C-Brace, KAFO/SCO; Device
Lead sponsor: Otto Bock Healthcare Products GmbH; Industry
Eligibility: 18 Years and older
Enrollment: 149 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 4
States / cities: Sarasota, Florida • Chicago, Illinois • Houston, Texas + 1 more

Conditions: Surgical Incisions
Interventions: Cicatricell Cream; Other
Lead sponsor: University of Toledo Health Science Campus; Other
Eligibility: 18 Years to 60 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Toledo, Ohio

Conditions: Attention Deficit Hyperactivity Disorder (ADHD), Deficient Emotional Self-Regulation (DESR)
Interventions: ADHD Medication, Omega-3 Fatty Acids; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 55 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Neurofibroma, Plexiform, Neurofibromatosis Type I
Interventions: tipifarnib, placebo; Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 3 Years to 25 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2009
U.S. locations: 11
States / cities: Birmingham, Alabama • Los Angeles, California • Chicago, Illinois + 8 more

Conditions: Physical Therapy
Interventions: FORCE therapeutics (physical therapy), Traditional Outpatient Physical Therapy; Procedure
Lead sponsor: Rothman Institute Orthopaedics; Other
Eligibility: 18 Years and older
Enrollment: 167 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Covid19
Interventions: STRI Formula, Placebo; Drug
Lead sponsor: Eyecheck, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 598 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 13
States / cities: Coral Gables, Florida • Doral, Florida • Medley, Florida + 4 more

Conditions: Bowel Preparation for Colonoscopy
Interventions: lubiprostone, placebo; Drug
Lead sponsor: Brooke Army Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 191 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Fort Sam Houston, Texas

Conditions: Chronic Bronchitis
Interventions: RejuvenAir System, Sham Control Procedure; Device
Lead sponsor: CSA Medical, Inc.; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 26
States / cities: Scottsdale, Arizona • Mountain View, California • Sacramento, California + 22 more

Conditions: Morbid Obesity, Pregnancy
Interventions: Misoprostol; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older · Female only
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Frailty, Inflammation
Interventions: Epigallocatechin-3-Gallate (EGCG) plus Ascorbic Acid (Vitamin C); Drug
Lead sponsor: University of Rochester; Other
Eligibility: 65 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Rochester, New York

Search by objective public record fields.

A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation

Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder

Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7

Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism

Antepartum Betamethasone Treatment for Prevention of Respiratory Distress in Infants Born by Elective Cesarean Section

Canola Oil Multi-center Intervention Trial II

Pilot Randomized Control Trial of Telehealth Group for Improving Peer Relationships (PEERS) in NF1

Parental Management of Young Children's Diabetes

Predictor of Clinical Response to Acthar in Myositis

Early Anatomy Scan for Evaluation of Obese Pregnant Women (EASE-O)

Long-Term Study of Nitisinone to Treat Alkaptonuria

Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery

UCSF BP Activate Letter Study

Clinical Trial Comparing C-Brace to Knee Ankle Foot Orthosis (KAFO)/Stance Control Orthosis (SCO)

Clinical Trial To Study The Anti-scarring Effect Of Cicatricell

Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits

R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

Traditional PT v Internet Based PT After Total Knee Arthroscopy

Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial

Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy

RejuvenAir® System Trial for COPD With Chronic Bronchitis

Induction of Labor in Morbidly Obese Patients

Reducing Frailty for Older Cancer Survivors Using Supplements